Publications by authors named "S Navaneethan"

Claim this Profile
I
Incident Pulmonary Hypertension and Its Risk Factors in CKD.
Marcelle Tuttle, Hocine Tighiouart, Tatsufumi Oka, Wendy McCallum, Nicholas S Hill, Sankar Navaneethan

Clin J Am Soc Nephrol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Assessment in Cardiovascular-Kidney-Metabolic Syndrome: An Opportunity to Individualize Evidence-Based Therapy in CKD.
L Parker Gregg, Biykem Bozkurt, Sankar D Navaneethan

Clin J Am Soc Nephrol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time for Broader Adoption of SGLT2 Inhibitors in Clinical Practice?
L Parker Gregg, Biykem Bozkurt, Sankar D Navaneethan

JAMA· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL study.
David C Wheeler, Kevin M Pantalone, Lixin Guo, Nihar R Desai, Ricardo Correa-Rotter, Sankar D Navaneethan

Clin Kidney J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Susan L Furth, Helen M Colhoun, Mehmet Kanbay, Aleksandra Kukla, Lee-Ling Lim, Sankar D Navaneethan

Kidney Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis